Fujian Fukang Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TETRACYCLINE HYDROCHLORIDE, with a corresponding US DMF Number 33499.
Remarkably, this DMF maintains an Active status since its submission on January 14, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 20, 2020, and payment made on March 18, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II